Catalyst Wire Dossier Catalyst Wire Dossier

Latanoprost 100 μg/mL

latanoprost · Pfizer Upjohn / Viatris
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Latanoprost 100 μg/mL, covering 2021-02-02 to 2021-02-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension [Phase 2]

See pricing